Adhesive capsulitis of the shoulder Musculoskeletal Diseases Adhesive capsulitis
Conditions
Interventions
Corticosteroid injection with or without a hydrodilatation procedure. Both treatment groups are given the following drugs in each injection:
1. 3 - 4 ml lopromide, Ultravist 300 Schering AG
2. 2 ml
Sponsors
Norwegian Research Council (Norway)
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Pain in one shoulder for more than 3 months but less than 2 years 2. Reduction in shoulder range of motion 3. Ability to fill out shoulder self-report form
Exclusion criteria
Exclusion criteria: 1. Age below 18 or over 70 2. Various contraindications to injection material 3. Restriction in range of motion for reasons other than capsulitis 4. Mental illness 5. Cancer 6. Current medication with corticosteroids
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Improvement in Shoulder Pain and Disability Index, measured 6 weeks after the last of three injections. | — |
Secondary
| Measure | Time frame |
|---|---|
| Shoulder range of motion for four different directions of passive and active movements are measured at baseline and then again six weeks after the last of the three injections. The score at follow-up is the outcome measure. | — |
Countries
Norway
Outcome results
None listed